设计用于改变GPCR G蛋白亚型选择性的全调节剂
Madelyn N Moore1, Kelsey L Person1, Valeria L Robleto1
1Department of Pharmacology, University of Minnesota Twin Cities, Minneapolis, MN, USA.
Nature
|October 22, 2025
概括
研究人员通过修改小分子选择性向G蛋白合受体 (GPCR) 的偏向性化合物. 这种方法可以通过控制G蛋白信号通路来定制更安全,更有效的药物发现.
科学领域:
- 药理学
- 分子生物学
- 药物发现
背景情况:
- G蛋白结合受体 (GPCRs) 通过G蛋白和β-arrestin调解细胞对细胞外信号的反应.
- 有偏差的化合物通过选择性地激活特定的信号通路提供了更安全,更有效的疗法.
- 了解GPCR偏差的决定因素对于合理的药物设计至关重要.
研究的目的:
- 调查与细胞内GPCR转换器接口结合的小分子如何影响G蛋白合特异性.
- 以结构为导向的,具有量身定制的G蛋白选择性的GPCR调节器的设计.
主要方法:
- 使用神经素受体1 (NTSR1) 作为A类GPCR模型.
- 使用小分子SBI-553及其衍生物探测细胞内受体-传感器接口.
- 评估G蛋白合选择性和发达的全调节剂的体内活性.
主要成果:
- 证明细胞内小分子可以以特定亚型的方式预测地改变GPCRG蛋白合.
- 通过转换器界面的直接相互作用,SBI-553被证明可以改变NTSR1的G蛋白偏好.
- 修改后的支架产生了具有明显的,独立于探针的G蛋白选择性概况的基调节剂.
结论:
- 通过针对受体-传感器接口的微小化学修改,可以精确调整GPCRG蛋白选择性.
- 由于保留了结合口袋,这一策略有望在广泛的GPCR超级家族中开发选择性药物.
相关概念视频
Transducer Mechanism: G Protein–Coupled Receptors
4.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.0K
GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Cooperative Allosteric Transitions
8.6K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.6K
Cooperative Allosteric Transitions
2.6K
2.6K
G Protein-coupled Receptors
16.5K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.5K


